170 related articles for article (PubMed ID: 25178941)
1. HBXIP expression predicts patient prognosis in breast cancer.
Cheng D; Liang B; Li Y
Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
[TBL] [Abstract][Full Text] [Related]
2. HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Wang Y; Sun J; Li N; Che S; Jin T; Liu S; Lin Z
J Ovarian Res; 2017 Apr; 10(1):26. PubMed ID: 28388957
[TBL] [Abstract][Full Text] [Related]
3. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
4. HBXIP over expression as an independent biomarker for cervical cancer.
Li N; Wang Y; Che S; Yang Y; Piao J; Liu S; Lin Z
Exp Mol Pathol; 2017 Feb; 102(1):133-137. PubMed ID: 28093193
[TBL] [Abstract][Full Text] [Related]
5. [HBXIP expression in gastric adenocarcinoma predicts poor prognosis].
Piao JJ; Li N; Wang YX; Lin ZH; Liu SP
Zhonghua Bing Li Xue Za Zhi; 2017 Feb; 46(2):88-92. PubMed ID: 28173666
[No Abstract] [Full Text] [Related]
6. Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
Cao L; Sun PL; Yao M; Jia M; Gao H
Hum Pathol; 2017 Oct; 68():166-174. PubMed ID: 28899737
[TBL] [Abstract][Full Text] [Related]
7. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
8. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
Xia H; Ma L; Li J; Bai H; Wang D
Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS3 is a novel poor prognostic factor for breast cancer.
Rui X; Li Y; Jin F; Li F
Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247
[TBL] [Abstract][Full Text] [Related]
10. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S
Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814
[TBL] [Abstract][Full Text] [Related]
11. Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer.
Xiao M; Li H; Yang S; Huang Y; Jia S; Wang H; Wang J; Li Z
J Surg Oncol; 2013 Apr; 107(5):456-62. PubMed ID: 22996179
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
13. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
[TBL] [Abstract][Full Text] [Related]
14. Sperm-associated antigen 9 overexpression correlates with poor prognosis and insensitive to Taxol treatment in breast cancer.
Yang C; Shen B; Zhang J; Zhang Q
Biomarkers; 2016; 21(1):62-7. PubMed ID: 26631164
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
16. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
[TBL] [Abstract][Full Text] [Related]
17. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.
Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z
J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab.
Wang X; Cai L; Ye F; Li M; Ma L; Geng C; Song Z; Liu Y
Medicine (Baltimore); 2019 Sep; 98(36):e16937. PubMed ID: 31490377
[TBL] [Abstract][Full Text] [Related]
20. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
